Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Bone Marrow Transplant From HLA Identical Related Donors for Patients With High Risk Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, Hemoglobin SB0/+ Thalassemia, or Homozygous B0/+ Thalassemia or Severe Variants of B0/+ Thalassemia

NCT00040469 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00040469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00040469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Bone Marrow Transplant From HLA Identical Related Donors for Patients With High Risk Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, Hemoglobin SB0/+ Thalassemia, or Homozygous B0/+ Thalassemia or Severe Variants of B0/+ Thalassemia
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2000
Completion date
November 21, 2003
Enrollment
15
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinopathy, sickle cell anemia, thalassemia